Amy P. Hsu

18.4k total citations · 3 hit papers
149 papers, 8.0k citations indexed

About

Amy P. Hsu is a scholar working on Immunology, Genetics and Epidemiology. According to data from OpenAlex, Amy P. Hsu has authored 149 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Immunology, 28 papers in Genetics and 26 papers in Epidemiology. Recurrent topics in Amy P. Hsu's work include Immunodeficiency and Autoimmune Disorders (50 papers), Blood disorders and treatments (21 papers) and Acute Myeloid Leukemia Research (18 papers). Amy P. Hsu is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (50 papers), Blood disorders and treatments (21 papers) and Acute Myeloid Leukemia Research (18 papers). Amy P. Hsu collaborates with scholars based in United States, Netherlands and United Kingdom. Amy P. Hsu's co-authors include Steven M. Holland, Paul F. Good, Daniel P. Perl, C. Warren Olanow, Eric J. Topol, Deepak P. Vivekananthan, Marc S. Penn, Shelly Sapp, Alexandra F. Freeman and P. Werner and has published in prestigious journals such as Nature, The Lancet and JAMA.

In The Last Decade

Amy P. Hsu

141 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome

2008 848 citations Alexandra F. Freeman, Joie Davis et al. profile →
Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials

2003 768 citations Amy P. Hsu et al. profile →
Evidence of neuronal oxidative damage in Alzheimer's disease.

1996 515 citations Paul F. Good, Amy P. Hsu et al. PubMed profile →

Peers

Countries citing papers authored by Amy P. Hsu

Since Specialization

Citations

This map shows the geographic impact of Amy P. Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy P. Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy P. Hsu more than expected).

Fields of papers citing papers by Amy P. Hsu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy P. Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy P. Hsu. The network helps show where Amy P. Hsu may publish in the future.

Co-authorship network of co-authors of Amy P. Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Amy P. Hsu. A scholar is included among the top collaborators of Amy P. Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy P. Hsu. Amy P. Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Known and Unknown “Knowns” of Human Susceptibility to Coccidioidomycosis 2024 ·Journal of Fungi ·Amy P. Hsu	2
2	Evaluating Cognitive Impairment in a Large Health Care System: The Cognition in Primary Care Program 2024 ·Journal of Alzheimer s Disease ·Barak Gaster, Monica Zigman Suchsland, Annette L. Fitzpatrick, Joshua M. Liao, Basia Belza, Amy P. Hsu, (unknown), Christina Park, Benjamin Olivari, Angad Singh, (unknown)	1
3	Genetic and Other Determinants for the Severity of Coccidioidomycosis: A Clinician’s Perspective 2023 ·Journal of Fungi ·John N. Galgiani, Amy P. Hsu, Daniel A. Powell, Jatin M. Vyas, Steven M. Holland	10
4	Examination of eQTL Polymorphisms Associated with Increased Risk of Progressive Complicated Sarcoidosis in European and African Descent Subjects 2023 ·PubMed ·Nancy G. Casanova, Sara M. Camp, Manuel L. Gonzalez‐Garay, Ken Batai, Lori Garman, Courtney G. Montgomery, Nathan A. Ellis, Rick A. Kittles, Christian Bime, Amy P. Hsu, Steven M. Holland, Yves A. Lussier, Jason H. Karnes, Nadera Sweiss, Lisa Maier, Laura L. Koth, David R. Möller, Naftali Kaminski, Joe G. N. Garcia	1
5	Mouse Model of a Human STAT4 Point Mutation That Predisposes to Disseminated Coccidiomycosis 2022 ·ImmunoHorizons ·Daniel A. Powell, Amy P. Hsu, Lisa F. Shubitz, (unknown), (unknown), Hien T. Trinh, Thomas Doetschman, Teodora Georgieva, (unknown), Justin E. Wilson, Marc J. Orbach, Steven M. Holland, John N. Galgiani, Jeffrey A. Frelinger	10
6	Pulmonary Manifestations of GATA2 Deficiency 2021 ·CHEST Journal ·Beatriz E. Marciano, Kenneth N. Olivier, Les Folio, Christa S. Zerbe, Amy P. Hsu, Alexandra F. Freeman, Armando Filie, Michael A. Spinner, Lauren Sanchez, (unknown), Mark Parta, Jennifer Cuellar‐Rodríguez, Dennis D. Hickstein, Steven M. Holland	29
7	MPEG1/perforin-2 mutations in human pulmonary nontuberculous mycobacterial infections 2017 ·JCI Insight ·Ryan McCormack, Eva P. Szymanski, Amy P. Hsu, Elena Pérez, Kenneth N. Olivier, (unknown), E. Brook Goodhew, Eckhard R. Podack, Steven M. Holland	25
8	Fatal CTLA ‐4 heterozygosity with autoimmunity and recurrent infections: a de novo mutation 2017 ·Clinical Case Reports ·Maria Francisca Moraes‐Fontes, Amy P. Hsu, Íris Caramalho, Catarina Martins, (unknown), (unknown), (unknown), (unknown), Steven M. Holland, Gülbû Uzel	4
9	Somatic mutations in children with GATA2-associated myelodysplastic syndrome who lack other features of GATA2 deficiency 2017 ·Blood Advances ·Kevin E. Fisher, Amy P. Hsu, Christopher L. Williams, (unknown), (unknown), M. Tarek Elghetany, Steven M. Holland, Alison A. Bertuch, M. Monica Gramatges	25
10	Novel signal transducer and activator of transcription 1 mutation disrupts small ubiquitin-related modifier conjugation causing gain of function 2017 ·Journal of Allergy and Clinical Immunology ·Elizabeth P. Sampaio, Li Ding, Stacey Rose, Phillip Cruz, Amy P. Hsu, Anuj Kashyap, Lindsey B. Rosen, Margery Smelkinson, Tatyana Almeida Tavella, Elise M. N. Ferré, (unknown), Christa S. Zerbe, Michail S. Lionakis, Steven M. Holland	17
11	NOVEL HETEROZYGOUS RAC2 MUTATION PRESENTING AS COMBINED IMMUNODEFICIENCY. 2016 ·Amy P. Hsu	0
12	Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations 2014 ·Blood ·Susan Price, Pamela A. Shaw, Amy E. Seitz, Gyan Joshi, Joie Davis, Julie E. Niemela, Katie Perkins, Ronald L. Hornung, Les Folio, Philip S. Rosenberg, Jennifer M. Puck, Amy P. Hsu, Bernice Lo, Stefania Pittaluga, Elaine S. Jaffe, Thomas A. Fleisher, V. Koneti Rao, Michael J. Lenardo	134
13	High-Sensitivity C-Reactive Protein in Acute Heart Failure: Insights From the ASCEND-HF Trial 2014 ·Journal of Cardiac Failure ·Andreas P. Kalogeropoulos, W.H. Wilson Tang, Amy P. Hsu, G. Michael Felker, Adrian F. Hernandez, Richard W. Troughton, Adriaan A. Voors, Stefan D. Anker, Marco Metra, John J.V. McMurray, Barry M. Massie, Justin A. Ezekowitz, Robert M. Califf, Christopher M. O’Connor, Randall C. Starling, Javed Butler	55
14	Comparative Assessment of Short-Term Adverse Events in Acute Heart Failure With Cystatin C and Other Estimates of Renal Function 2014 ·JACC Heart Failure ·W.H. Wilson Tang, Matthias Dupont, Adrian F. Hernandez, Adriaan A. Voors, Amy P. Hsu, G. Michael Felker, Javed Butler, Marco Metra, Stefan D. Anker, Richard W. Troughton, Stephen S. Gottlieb, John J.V. McMurray, Paul W. Armstrong, Barry M. Massie, Robert M. Califf, Christopher M. O’Connor, Randall C. Starling	35
15	Autoimmune lymphoproliferative syndrome due to FAS mutations outside the signal-transducing death domain: molecular mechanisms and clinical penetrance 2012 ·Genetics in Medicine ·Amy P. Hsu, Kennichi Dowdell, Joie Davis, Julie E. Niemela, Stacie M. Anderson, Pamela A. Shaw, V. Koneti Rao, Jennifer M. Puck	25
16	Interleukin-12 Receptor 1 Deficiency Predisposing to Disseminated Coccidioidomycosis 2011 ·Clinical Infectious Diseases ·Donald C. Vinh, B. Schwartz, Amy P. Hsu, (unknown), Patricia Valdez, Danielle Fink, (unknown), (unknown), Douglas B. Kuhns, Gülbû Uzel, Stefania Pittaluga, Susan Hoover, J N Galgiani, Steven M. Holland	70
17	CLUE: a randomized comparative effectiveness trial of IV nicardipine versus labetalol use in the emergency department 2011 ·Critical Care ·W. Frank Peacock, Joseph Varón, Brigitte M. Baumann, Pierre Borczuk, Chad Cannon, Abhinav Chandra, David Cline, Deborah B. Diercks, Brian Hiestand, Amy P. Hsu, (unknown), (unknown), Philip Levy, Richard M. Nowak, Jon W. Schrock	38
18	The association between early ventricular arrhythmias, renin-angiotensin-aldosterone system antagonism, and mortality in patients with ST-segment-elevation myocardial infarction: Insights from global use of strategies to open coronary arteries (GUSTO) V 2009 ·American Heart Journal ·Arman T. Askari, Mehdi H. Shishehbor, (unknown), Michael Riley, Amy P. Hsu, A. Michael Lincoff	29
19	Mutations causing severe combined immunodeficiency: detection with a custom resequencing microarray 2008 ·Genetics in Medicine ·(unknown), (unknown), Amy P. Hsu, Elaine Mansfield, Janet A. Warrington, Jennifer M. Puck	26
20	A laser microprobe mass analysis of trace elements in brain mineralizations and capillaries in Fahr's disease 1996 ·Acta Neuropathologica ·Constantin Bouras, Pantéleimon Giannakopoulos, Paul F. Good, Amy P. Hsu, (unknown), D. P. Perl	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact